AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 10480775 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated telephone disease management (ATDM) calls for 12 months
Number of subjects: 252
Study 9110065 — intervention group
Group type: COMPARATOR
Intervention: Intravenous ganciclovir (5 mg/kg per day)
Number of subjects: 0
Study 9110065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (500 mg six times a day)
Number of subjects: 0
Study 9110065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir (1000 mg three times a day)
Number of subjects: 0
Study 9110065 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir
Number of subjects: 0
Study 1901199 — intervention group
Group type: EXPERIMENTAL
Intervention: Z6noS (pyrazinamide for 6 months without streptomycin)
Number of subjects: 1386
Study 1901199 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifater (combined formulation of isoniazid, rifampin, and pyrazinamide)
Number of subjects: 1386
Study 1901199 — intervention group
Group type: COMPARATOR
Intervention: Separate drugs (isoniazid, rifampin, and pyrazinamide administered separately)
Number of subjects: 1386
Study 6759958 — intervention group
Group type: EXPERIMENTAL
Intervention: CDP Choline
Number of subjects: 60
Study 6759958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31532574 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 25
Study 31532574 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 30946312 — intervention group
Group type: EXPERIMENTAL
Intervention: Zao Ren An Shen capsule
Number of subjects: 90
Study 30946312 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study 30420286 — intervention group
Group type: EXPERIMENTAL
Intervention: PTH‐ICGT group
Number of subjects: 127
Study 30420286 — intervention group
Group type: COMPARATOR
Intervention: Conventional naked eye group
Number of subjects: 127
Study 26330424 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative statin therapy
Number of subjects: 2845
Study 26330424 — intervention group
Group type: COMPARATOR
Intervention: Control group (no statin therapy)
Number of subjects: 2845
Study 23805813 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus oral hygiene instruction
Number of subjects: 160
Study 22297311 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-session smoking reduction intervention
Number of subjects: 53
Study 22297311 — intervention group
Group type: COMPARATOR
Intervention: Waiting list (control)
Number of subjects: 53
Study 20473066 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 50, 100, 200, or 400 mg/d
Number of subjects: 1808
Study 20473066 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine
Number of subjects: 1808
Study 20473066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1808
Study 17505516 — intervention group
Group type: EXPERIMENTAL
Intervention: Epirubicin-vinorelbine (Epi-Vnr)
Number of subjects: 482
Study 17505516 — intervention group
Group type: COMPARATOR
Intervention: FEC100
Number of subjects: 482
Study 15857225 — intervention group
Group type: EXPERIMENTAL
Intervention: Modem transfer of BG data
Number of subjects: 47
Study 15857225 — intervention group
Group type: COMPARATOR
Intervention: Telephone communication of BG data
Number of subjects: 47
Study 11885569 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan (TRP) depletion (100 g of an amino acid mixture without TRP)
Number of subjects: 27
Study 11885569 — intervention group
Group type: COMPARATOR
Intervention: Placebo (100 g of an amino acid mixture with TRP)
Number of subjects: 27
Study 9579820 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive biomagnetic imaging using a multiple dipole model
Number of subjects: 4
Study 7747571 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 13
Study 7747571 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 2501032 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (3.3 cm2)
Number of subjects: 30
Study 2501032 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (6.7 cm2)
Number of subjects: 30
Study 2501032 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (13.3 cm2)
Number of subjects: 30
Study 2501032 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (20 cm2)
Number of subjects: 30
Study 2501032 — intervention group
Group type: EXPERIMENTAL
Intervention: All patch sizes
Number of subjects: 30
Study 28832429 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral conjugated equine estrogens (o-CEE; 0.45 mg/d)
Number of subjects: 653
Study 28832429 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β-estradiol (t-E2; 50 μg/d) plus cyclic progesterone (200 mg)
Number of subjects: 653
Study 28832429 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 653
Study 28832429 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal 17β-estradiol (t-E2)
Number of subjects: 653
Study 28832429 — intervention group
Group type: EXPERIMENTAL
Intervention: Both HT formulations (o-CEE and t-E2)
Number of subjects: 653
Study 27555179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (DEX) 1 μg/kg
Number of subjects: 90
Study 27555179 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine (DEX) 2 μg/kg
Number of subjects: 90
Study 27555179 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 90
Study 24286456 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg of GW766994 twice daily for 10 days followed by prednisone 30 mg for 5 days
Number of subjects: 60
Study 24286456 — intervention group
Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 60
Study 22828538 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic pyloromyotomy (Group A)
Number of subjects: 30
Study 22828538 — intervention group
Group type: COMPARATOR
Intervention: Open pyloromyotomy (Group B)
Number of subjects: 30
Study 20674830 — intervention group
Group type: EXPERIMENTAL
Intervention: Montelukast (5 mg, chewable tablet)
Number of subjects: 1162
Study 20674830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1162
Study 19025280 — intervention group
Group type: EXPERIMENTAL
Intervention: Stage-based behavioral counseling (SBC) provided by a nurse
Number of subjects: 60
Study 19025280 — intervention group
Group type: COMPARATOR
Intervention: Educational digital video disc (DVD)
Number of subjects: 60
Study 15992231 — intervention group
Group type: EXPERIMENTAL
Intervention: Meditation (30 minutes audiotape, twice a day for 12 weeks, plus weekly meetings)
Number of subjects: 19
Study 15992231 — intervention group
Group type: COMPARATOR
Intervention: Control group (weekly meetings only)
Number of subjects: 19
Study 12790212 — intervention group
Group type: EXPERIMENTAL
Intervention: Bispectral index monitoring
Number of subjects: 60
Study 12790212 — intervention group
Group type: COMPARATOR
Intervention: Control group (no bispectral index monitoring)
Number of subjects: 60
Study 11514924 — intervention group
Group type: EXPERIMENTAL
Intervention: Acamprosate
Number of subjects: 521
Study 11514924 — intervention group
Group type: COMPARATOR
Intervention: Other therapy
Number of subjects: 521
Study 9422018 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral metronidazole (400 mg) twice daily for two days at 24 weeks of gestation
Number of subjects: 879
Study 8181027 — intervention group
Group type: EXPERIMENTAL
Intervention: Organic nitrates
Number of subjects: 0
Study 8181027 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrates in combination with hydralazine
Number of subjects: 0
Study 8181027 — intervention group
Group type: COMPARATOR
Intervention: Nitrate therapy without hydralazine
Number of subjects: 0
Study 8181027 — intervention group
Group type: COMPARATOR
Intervention: Nitrates in patients treated with ACE inhibitors
Number of subjects: 0
Study 3325255 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 100mg
Number of subjects: 60
Study 3325255 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofloxacin 200mg
Number of subjects: 60
Study 2778203 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative teaching methods (experimental groups)
Number of subjects: 20
Study 2778203 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture/demonstration format (control groups)
Number of subjects: 20
Study 31934773 — intervention group
Group type: EXPERIMENTAL
Intervention: BackX™
Number of subjects: 18
Study 31934773 — intervention group
Group type: EXPERIMENTAL
Intervention: Laevo™
Number of subjects: 18
Study 31934773 — intervention group
Group type: COMPARATOR
Intervention: Control (unsupported conditions)
Number of subjects: 18
Study 31123075 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite outcome MAPE (major adverse peritoneal events)
Number of subjects: 1720
Study 31123075 — intervention group
Group type: COMPARATOR
Intervention: Individual outcomes (technical failure, peritonitis, peritoneal membrane deterioration)
Number of subjects: 1720
Study 27602705 — intervention group
Group type: EXPERIMENTAL
Intervention: Text Messaging (TM) intervention with 2-way reminders about medication administration.
Number of subjects: 51
Study 27602705 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control group).
Number of subjects: 51
Study 26397085 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised spinal stabilization exercises (weekly physical therapy for 8 weeks)
Number of subjects: 34
Study 26397085 — intervention group
Group type: COMPARATOR
Intervention: 1-time treatment followed by home exercises (unsupervised group)
Number of subjects: 34
Study 23503913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol (15 mg/kg)
Number of subjects: 120
Study 23503913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dipyrone (15 mg/kg)
Number of subjects: 120
Study 23503913 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 120
Study 23503913 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous paracetamol and dipyrone
Number of subjects: 120
Study 21054767 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise stress test
Number of subjects: 36
Study 18834691 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling by Farquhar's six‐step method for 10 min after traditional oral hygiene instruction.
Number of subjects: 38
Study 18834691 — intervention group
Group type: COMPARATOR
Intervention: Traditional oral hygiene instruction for 20 min.
Number of subjects: 38
Study 17120180 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg hydrochlorothiazide daily
Number of subjects: 185
Study 17120180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study 15133938 — intervention group
Group type: EXPERIMENTAL
Intervention: Java mobile phone-based Home Helper care report creation support system
Number of subjects: 0
Study 15133938 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study 11133604 — intervention group
Group type: EXPERIMENTAL
Intervention: NAD 6000 ventilator
Number of subjects: 20
Study 11133604 — intervention group
Group type: COMPARATOR
Intervention: Servo 900C ventilator
Number of subjects: 20
Study 9632123 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg acarbose with 100 g sucrose
Number of subjects: 11
Study 9632123 — intervention group
Group type: COMPARATOR
Intervention: Placebo with 100 g sucrose
Number of subjects: 11
Study 8534382 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitive/Tartar Control dentifrice (5.0% potassium nitrate, 1.3% soluble pyrophosphate, 1.5% PVM/MA copolymer, 0.243% sodium fluoride)
Number of subjects: 97
Study 8534382 — intervention group
Group type: COMPARATOR
Intervention: Sensodyne-F dentifrice (5% potassium nitrate, 0.76% sodium monofluorophosphate)
Number of subjects: 97
Study 3205904 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous oxytocin (OT) infusion
Number of subjects: 0
Study 30947270 — intervention group
Group type: EXPERIMENTAL
Intervention: Flipped Classroom (FT) methodology
Number of subjects: 110
Study 30947270 — intervention group
Group type: COMPARATOR
Intervention: Lecture-Based (LB) methodology
Number of subjects: 110
Study 28889724 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment group (entecavir and adefovir dipivoxil)
Number of subjects: 90
Study 28889724 — intervention group
Group type: COMPARATOR
Intervention: Entecavir group
Number of subjects: 90
Study 26306883 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) in addition to traditional physical therapy, administered three times per week for three months.
Number of subjects: 30
Study 26306883 — intervention group
Group type: COMPARATOR
Intervention: Pulsed electromagnetic field (PEMF) in addition to traditional physical therapy, administered three times per week for three months.
Number of subjects: 30
Study 23262158 — intervention group
Group type: EXPERIMENTAL
Intervention: VR-based exercise program (n=18) for 8 weeks
Number of subjects: 32
Study 23262158 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=14) continuing daily routine for 8 weeks
Number of subjects: 32
Study 22011432 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey meal
Number of subjects: 11
Study 22011432 — intervention group
Group type: COMPARATOR
Intervention: Cod meal
Number of subjects: 11
Study 22011432 — intervention group
Group type: COMPARATOR
Intervention: Casein meal
Number of subjects: 11
Study 22011432 — intervention group
Group type: COMPARATOR
Intervention: Gluten meal
Number of subjects: 11
Study 18444531 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Controlled Analgesia (PCA)
Number of subjects: 66
Study 18444531 — intervention group
Group type: COMPARATOR
Intervention: Continuous Epidural Analgesia (Bupivacaine 0.125% + 5 microg/ml of Fentanyl, 6-10 ml/h)
Number of subjects: 66
Study 18444531 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Controlled Epidural Analgesia (Bupivacaine 0.08% + 3 microg/ml of Fentanyl, 6 ml/h and bolus of 5 ml)
Number of subjects: 66
Study 16165104 — intervention group
Group type: EXPERIMENTAL
Intervention: LI160 (2 x 750 mg)
Number of subjects: 16
Study 16165104 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 12685136 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrial septal pacing (Se-P)
Number of subjects: 56
Study 12685136 — intervention group
Group type: COMPARATOR
Intervention: Atrial appendage pacing (Ap-P)
Number of subjects: 56
Study 10810847 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal couple group intervention (TG)
Number of subjects: 35
Study 10810847 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 35
Study 8772586 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological dose of GH (0.04 U/kg)
Number of subjects: 7
Study 8772586 — intervention group
Group type: EXPERIMENTAL
Intervention: Supraphysiological dose of GH (0.08 U/kg)
Number of subjects: 7
Study 8772586 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study 1739068 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured glass ionomer (Zionomer) tested at 1 hour
Number of subjects: 52
Study 1739068 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured glass ionomer (Zionomer) tested at 24 hours
Number of subjects: 52
Study 1739068 — intervention group
Group type: COMPARATOR
Intervention: Chemically cured glass ionomer (Ketac-Bond) tested at 1 hour
Number of subjects: 52
Study 1739068 — intervention group
Group type: COMPARATOR
Intervention: Chemically cured glass ionomer (Ketac-Bond) tested at 24 hours
Number of subjects: 52
Study 1739068 — intervention group
Group type: EXPERIMENTAL
Intervention: Both glass ionomers tested at 1 hour and 24 hours
Number of subjects: 52
Study 1739068 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured glass ionomer (Zionomer) tested at 1 hour and 24 hours
Number of subjects: 52
Study 1739068 — intervention group
Group type: COMPARATOR
Intervention: Chemically cured glass ionomer (Ketac-Bond) tested at 1 hour and 24 hours
Number of subjects: 52
Study 6503959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperative radiotherapy (total dose 5000 rads, with 3000 rads preoperative) and adjuvant chemotherapy (FT-207, 600mg/day for over 3 months) in group A.
Number of subjects: 19
Study 6503959 — intervention group
Group type: COMPARATOR
Intervention: Postoperative radiotherapy alone in group B.
Number of subjects: 19
Study 6503959 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre- and postoperative radiotherapy in group A.
Number of subjects: 19
Study 31721812 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (20 Hz) for abdominal muscles, 60 sessions over 12 weeks (23 min/session, 5 days/week)
Number of subjects: 24
Study 31721812 — intervention group
Group type: COMPARATOR
Intervention: Control group continued usual training
Number of subjects: 24
Study 30540367 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomography and Biomechanical Index (TBI)
Number of subjects: 0
Study 30540367 — intervention group
Group type: EXPERIMENTAL
Intervention: Belin/Ambrósio Enhanced Ectasia Display (BAD‐D) index
Number of subjects: 0
Study 30540367 — intervention group
Group type: EXPERIMENTAL
Intervention: Corvis Biomechanical Index (CBI)
Number of subjects: 0
Study 30540367 — intervention group
Group type: COMPARATOR
Intervention: Cut-offs from Ambrósio et al. (2017)
Number of subjects: 0
Study 27288812 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 42
Study 27288812 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 24813670 — intervention group
Group type: EXPERIMENTAL
Intervention: Classroom-based cognitive behaviour therapy (CBT)
Number of subjects: 3357
Study 24813670 — intervention group
Group type: COMPARATOR
Intervention: Usual school provision of Personal Social and Health Education (Control)
Number of subjects: 3357
Study 23203358 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Goals Collaborative Care (LGCC)
Number of subjects: 68
Study 23203358 — intervention group
Group type: COMPARATOR
Intervention: Enhanced treatment as usual
Number of subjects: 68
Study 21047406 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta-blockers at admission
Number of subjects: 314
Study 21047406 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral beta-blockers before hospital discharge
Number of subjects: 314
Study 21047406 — intervention group
Group type: COMPARATOR
Intervention: No beta-blocker therapy
Number of subjects: 314
Study 19041594 — intervention group
Group type: EXPERIMENTAL
Intervention: Woman Abuse Screening Tool (WAST)
Number of subjects: 5607
Study 19041594 — intervention group
Group type: COMPARATOR
Intervention: Composite Abuse Scale (CAS)
Number of subjects: 5607
Study 19041594 — intervention group
Group type: EXPERIMENTAL
Intervention: Characteristics associated with being positive on both WAST and CAS
Number of subjects: 5607
Study 16109054 — intervention group
Group type: COMPARATOR
Intervention: eletriptan 40 mg
Number of subjects: 19
Study 16109054 — intervention group
Group type: COMPARATOR
Intervention: eletriptan 20 mg
Number of subjects: 19
Study 16109054 — intervention group
Group type: EXPERIMENTAL
Intervention: sumatriptan 100 mg
Number of subjects: 19
Study 12439034 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulocyte colony-stimulating factor (G-CSF)
Number of subjects: 512
Study 12439034 — intervention group
Group type: COMPARATOR
Intervention: No G-CSF
Number of subjects: 512
Study 10088733 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac tromethamine 0.5% ophthalmic solution (Acular) administered four times daily for 14 days
Number of subjects: 102
Study 10088733 — intervention group
Group type: COMPARATOR
Intervention: Vehicle solution administered four times daily for 14 days
Number of subjects: 102
Study 7487290 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid
Number of subjects: 35
Study 7487290 — intervention group
Group type: COMPARATOR
Intervention: High dose aprotinin
Number of subjects: 35
Study 2181254 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravaginal brachytherapy
Number of subjects: 108
Study 2181254 — intervention group
Group type: COMPARATOR
Intervention: Intraoperative rinsing of the vagina with alcohol and suturing of the cervical canal
Number of subjects: 108
Study 624779 — intervention group
Group type: EXPERIMENTAL
Intervention: Furosemide
Number of subjects: 11
Study 624779 — intervention group
Group type: EXPERIMENTAL
Intervention: Bumetanide
Number of subjects: 11
Study 31609707 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO4) and melatonin
Number of subjects: 60
Study 31609707 — intervention group
Group type: COMPARATOR
Intervention: Melatonin only
Number of subjects: 60
Study 28559400 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blockers
Number of subjects: 2527
Study 28559400 — intervention group
Group type: COMPARATOR
Intervention: No β-blockers
Number of subjects: 2527
Study 26386784 — intervention group
Group type: EXPERIMENTAL
Intervention: FFR-guided PCI with new-generation stents
Number of subjects: 0
Study 26386784 — intervention group
Group type: COMPARATOR
Intervention: CABG
Number of subjects: 0
Study 22612557 — intervention group
Group type: EXPERIMENTAL
Intervention: MobileMums intervention
Number of subjects: 88
Study 22612557 — intervention group
Group type: COMPARATOR
Intervention: Minimal-contact control condition
Number of subjects: 88
Study 21903907 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE-I)
Number of subjects: 6337
Study 21903907 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6337
Study 21903907 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (ACE-I) in patients who continued therapy despite early WRF
Number of subjects: 6337
Study 18155200 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic surgery to correct uterine septa, intrauterine synechiae, and myomas
Number of subjects: 0
Study 18155200 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of endometrial polyps
Number of subjects: 0
Study 18155200 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for complex congenital anomalies (e.g., unicornuate uterus, uterus didelphys)
Number of subjects: 0
Study 16792136 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent oral alfacalcidol (2 microg after each dialysis session)
Number of subjects: 34